Literature DB >> 1451966

Predictors of outcome in patients with achalasia treated by pneumatic dilation.

V F Eckardt1, C Aignherr, G Bernhard.   

Abstract

This prospective study investigates whether the effect of pneumatic dilation in patients with achalasia can be predicted on the basis of patient characteristics, type of treatment, or results of postdilation investigations. Over a period of 10 years, 54 consecutive patients with newly diagnosed achalasia were treated with pneumatic dilation and underwent pretreatment and posttreatment manometric, radiographic, and scintigraphic investigations. They were followed up every 2 years until the fall of 1991. Among the factors evaluated in the initial examination, only young age adversely affected outcome (P < 0.05). With the exception of the diameter of the dilating balloon, the treatment characteristics had a low predictive value. Postdilation lower esophageal sphincter pressure was the single most valuable factor for predicting the long-term clinical response (P < 0.0005). However, patients with high sphincter pressures and poor treatment results benefited from repeated dilations by having progressively longer remissions. It is concluded that young patients are poor candidates for pneumatic dilation, that treatment should be aimed at near complete inflation of the dilating bag, and that postdilation sphincter pressure may guide further treatment.

Entities:  

Mesh:

Year:  1992        PMID: 1451966     DOI: 10.1016/0016-5085(92)91428-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  162 in total

Review 1.  An antireflux procedure is critical to the long-term outcome of esophageal myotomy for achalasia.

Authors:  J H Peters
Journal:  J Gastrointest Surg       Date:  2001 Jan-Feb       Impact factor: 3.452

Review 2.  Practical approaches to dysphagia caused by esophageal motor disorders.

Authors:  A S Arora; J L Conklin
Journal:  Curr Gastroenterol Rep       Date:  2001-06

3.  Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin.

Authors:  C Cuillière; P Ducrotté; F Zerbib; E H Metman; D de Looze; F Guillemot; H Hudziak; H Lamouliatte; J C Grimaud; A Ropert; M Dapoigny; R Bost; M Lémann; M A Bigard; P Denis; J L Auget; J P Galmiche; S Bruley des Varannes
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

4.  Guidelines on the use of oesophageal dilatation in clinical practice.

Authors:  S A Riley; S E A Attwood
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

5.  Evaluating the reliability and construct validity of the Eckardt symptom score as a measure of achalasia severity.

Authors:  T H Taft; D A Carlson; J Triggs; J Craft; K Starkey; R Yadlapati; D Gregory; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2018-01-08       Impact factor: 3.598

6.  Chest trauma and aetiology of achalasia.

Authors:  R Penagini; P Cantù; A Grigolon
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

7.  Long-term results of conventional myotomy in patients with achalasia: a prospective 20-year analysis.

Authors:  Ines Gockel; Theodor Junginger; Volker F Eckardt
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

8.  Pneumatic dilation for achalasia: late results of a prospective follow up investigation.

Authors:  V F Eckardt; I Gockel; G Bernhard
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  High-Resolution Impedance Manometry Metrics of the Esophagogastric Junction for the Assessment of Treatment Response in Achalasia.

Authors:  Dustin A Carlson; Zhiyue Lin; Peter J Kahrilas; Joel Sternbach; Eric S Hungness; Nathaniel J Soper; Michelle Balla; Zoe Listernick; Michael Tye; Katherine Ritter; Jenna Craft; Jody D Ciolino; John E Pandolfino
Journal:  Am J Gastroenterol       Date:  2016-10-04       Impact factor: 10.864

10.  Long-term outcome of peroral endoscopic myotomy for esophageal achalasia in patients with previous Heller myotomy.

Authors:  Helle Ø Kristensen; Jakob Kirkegård; Daniel Willy Kjær; Frank Viborg Mortensen; Rastislav Kunda; Niels Christian Bjerregaard
Journal:  Surg Endosc       Date:  2016-10-03       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.